About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,820 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,820 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4261-4280 of 10,820 trials

CompletedA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of MigraineStudy STS101-002 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101…NCT03901482·Birmingham, Alabama and 116 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedA Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)The purpose of this study evaluates the efficacy and safety of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants who were heterozygous for F508del and a…NCT05033080·Birmingham, Alabama and 138 others

CompletedNutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2By 2030 an estimated 2 million people in the US will need dialysis or transplantation for advanced kidney failure.NCT02278562·Nashville, Tennessee

CompletedPhase III Cat-PAD StudyThe purpose of this study is to compare the treatment effect of two treatment regimens of Cat-PAD vs placebo and to evaluates the treatment effect of Cat-PAD on symptoms, rescue…NCT01620762·Rolling Hills Estates, California and 117 others

RecruitingAI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.Hospital-acquired blood clots (HA-VTE) are the leading cause of death in hospitalized patients in the US.NCT06939803·Nashville, Tennessee

RecruitingEvaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric InsomniaThis is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female…NCT06953869·Dothan, Alabama and 34 others

RecruitingA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsThe purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including…NCT06465069·Duarte, California and 39 others

TerminatedEfficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss TreatmentThe primary objective of the trial is the confirmation of the efficacy of AM-111 in the recovery of severe to profound idiopathic sudden sensorineural hearing loss (ISSNHL).NCT02809118·Birmingham, Alabama and 50 others

Active not recruitingAn Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell LymphomaThe purpose of this study is to compare the efficacy and safety of glofitamab in combination with polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone…NCT06047080·Anchorage, Alaska and 228 others

CompletedBioelectrical Impedance for Self-monitoring of Lymphedema* Breast cancer treatment-related lymphedema requires life-long self-care is required.NCT01385488·Nashville, Tennessee

CompletedA Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.This study will investigate the safety, efficacy and pharmacokinetics of R3421 in patients with moderate to severe chronic plaque psoriasis.NCT00504270·Hot Springs, Arkansas and 14 others

CompletedPrecision-Based Magnesium TrialColorectal cancer is the fourth most common incident cancer and the second most common cause of cancer death in the United States, with approximately 150,000 new cases and 57,000…NCT01105169·Nashville, Tennessee

CompletedStudy Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.This study will compare bifeprunox to a currently marketed medication, Zyprexa (olanzapine), with respect to the affect on weight during the treatment of outpatients with…NCT00380224·Little Rock, Arkansas and 66 others

Active not recruitingTesting the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent GlioblastomaThis phase II trial studies the best dose and effect of tocilizumab in combination with atezolizumab and stereotactic radiation therapy in treating glioblastoma patients whose…NCT04729959·Anaheim, California and 109 others

CompletedTrial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant ChemotherapyThe investigators propose to evaluate eribulin as adjuvant therapy in breast cancer patients who have residual invasive disease in breast or lymph node tissue following standard…NCT01401959·Fort Myers, Florida and 17 others

CompletedEvaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of AneurysmsThe purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending…NCT00590759·Phoenix, Arizona and 24 others

CompletedA Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesThe purpose of this study is to determine the safety and efficacy of albiglutide in subjects with type 2 diabetesNCT00839527·Alabaster, Alabama and 357 others

CompletedEN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)A Phase 2, Open-Label Extension Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy (commonly known as Cellulite).NCT02942160·Beverly Hills, California and 14 others

RecruitingGenetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC StudyThis phase II trial tests whether using genetic testing of tumor tissue to select the optimal treatment regimen works in treating patients with clear cell renal cell (kidney)…NCT05361720·Duarte, California and 5 others

CompletedShort Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)To compare the antiviral efficacy and safety of a 12-week with a 24-week treatment of BI 201335 at a dose of 120 mg once daily, with a 24-week background of pegylated…NCT00984620·Tulepo, Mississippi and 27 others

PreviousPage 214 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville